, and a new parameter describing the sensitivity of EGP to the inhibitory effect of insulin (IC50 ϭ 0.0195 Ϯ 0.0046 min Ϫ1 ). The model additionally provided an estimate of the time course of EGP showing almost immediate inhibition, followed by a secondary inhibitory effect caused by infusion of insulin, and a large overshoot as EGP returns to its basal value. Our estimates show very good agreement with those obtained via deconvolution and the model-independent TTR clamp technique. These results suggest that the new integrated model can serve as a simple one-step approach to obtain metabolic indexes while also providing a parametric description of EGP.hot minimal model; intravenous glucose tolerance test; mathematical modeling; insulin sensitivity AS THE BODY'S MAIN SOURCE of endogenous glucose production (EGP), the liver plays a crucial role in maintaining normal glucose homeostasis. In response to a glucose challenge, insulin is secreted, and the resultant hyperglycemia and hyperinsulinemia conspire to suppress hepatic glucose production and stimulate glucose uptake in splanchnic and peripheral tissues. During the course of disease progression, however, the liver may become resistant to the suppressive effects of glucose and insulin on glucose production. The resulting excess production acts to maintain the chronic hyperglycemic state observed in type 2 diabetics. It is therefore of great interest to accurately assess the dynamic regulation of EGP in response to a glucose perturbation.The dynamic picture emerging from glucose and insulin's time course after an intravenous glucose tolerance test (IVGTT) has allowed remarkable and unique insights into the pathophysiology of glucose homeostasis (8), especially when coupled with the parametric information available when the data are analyzed with the minimal model of glucose disappearance (9). Over the years, the metabolic indexes of glucose effectiveness (3) and insulin sensitivity (38) estimated via the minimal model have been subjected to experimental validation against equivalent experimental designs, and insulin sensitivity has been found to be an informative predictor of cardiovascular risk (27) and to be strongly related to genetic factors (10). New protocols that modify the standard IVGTT to facilitate minimal-model parameter estimation have also been proposed, such as an infusion of insulin (22) or tolbutamide administration (7) and variations thereof (39,40).Among other modifications of the standard IVGTT, the addition of a tracer of glucose to the glucose bolus was proposed as a way to dissect the respective roles of liver and periphery in glucose dynamics (14). This augmented information allowed clarification of the impact of some of the underlying assumptions of the original minimal model, in particular the single-compartment approximation for glucose distribution (15), which does not allow a plausible estimate of EGP in the early portion of the test, and seems to impact the estimate of glucose effectiveness more severely than it does insulin sensitiv...